IL-1β and TNFα Cooperativity in Regulating IL-6 Expression in Adipocytes Depends on CREB Binding and H3K14 Acetylation

Abstract

IL-6 was found to be overexpressed in the adipose tissue of obese individuals, which may cause insulin resistance. However, the regulation of IL-6 in adipocytes in obesity setting remains to be explored. Since IL-1β and TNFα are increased in obese adipose tissue and promote inflammation, we investigated whether cooperation between IL-1β and TNFα influences the production of IL-6. Our data show that IL-1β and TNFα cooperatively enhance IL-6 expression in 3T3L-1 adipocytes. Similar results were seen in human adipocytes isolated from subcutaneous and visceral fat. Although adipocytes isolated from lean and obese adipose tissues showed similar responses for production of IL-6 when incubated with IL-1β/TNFα, secretion of IL-6 was higher in adipocytes from obese tissue. TNFα treatment enhanced CREB binding at CRE locus, which was further enhanced with IL-1β, and was associated with elevated histone acetylation at CRE locus. On the other hand, IL-1β treatments mediated C/EBPβ binding to NF-IL-6 consensus, but not sufficiently to mediate significant histone acetylation. Interestingly, treatment with both stimulatory factors amplifies CREB binding and H3K14 acetylation. Furthermore, histone acetylation inhibition by anacardic acid or curcumin reduces IL-6 production. Notably, inhibition of histone deacetylase (HDAC) activity by trichostatin A (TSA) resulted in the further elevation of IL-6 expression in response to combined treatment of adipocytes with IL-1β and TNFα. In conclusion, our results show that there is an additive interaction between IL-1β and TNFα that depends on CREB binding and H3K14 acetylation, and leads to the elevation of IL-6 expression in adipocytes, providing interesting pathophysiological connection among IL-1β, TNFα, and IL-6 in settings such as obesity.

Multi-organ single-cell analysis reveals an on/off switch system with potential for personalized treatment of immunological diseases

“…However, for IL-1α, a significant drop in protein expression level was seen at later stages of the disease. IL-6 and interferon γ (IFN-γ), which are known to interact with IL-1β and TNF, 18 , 19 , 20 , 21 also showed variable changes in expression level at different time points of disease. Such variations could be consistent with dynamic changes in organ inflammation in CIA.…”

Si-Wu Water Extracts Protect against Colonic Mucus Barrier Damage by Regulating Muc2 Mucin Expression in Mice Fed a High-Fat Diet

“…Additionally, both TNF-α and IL-1β are sufficient to induce IL-6 promoter activity, both signaling pathways are required for IL-6 active transcription. Different from TNF-α, IL-1β may generate a temporal binding of C/EBPβ to NF-IL-6 consensus to induce the secretion of IL-6 [ 53 ]. Besides, TNF-α-induced IL-1β production was significantly blocked by inhibition of long-chain acyl-CoA synthetase 1 (ACSL-1) activity [ 3 ].…”

Dectin-1 as a Potential Inflammatory Biomarker for Metabolic Inflammation in Adipose Tissue of Individuals with Obesity

“…This study cohort included 59 nondiabetic individuals from both sexes who were recruited in the study at the Dasman Diabetes Institute, Kuwait. The exclusion criteria included pregnant women and individuals with diseases, such as lung, heart, kidney, or liver complications, immune dysfunction, diabetes, cancers, or hematologic disorders as previously described [ 34 , 35 , 36 ]. Using the standard formula for the body mass index (BMI) (BMI = body weight (kg)/height 2 (m 2 )), the cohort was divided into 10 lean (BMI < 25 kg/m 2 ), 20 overweight (25 ≤ BMI < 30 kg/m 2 ), and 29 obese (BMI ≥ 30 kg/m 2 ) individuals.…”